{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T12:44:45Z","timestamp":1781613885182,"version":"3.54.5"},"publisher-location":"Berlin, Heidelberg","reference-count":199,"publisher":"Springer Berlin Heidelberg","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1007\/82_2025_339","type":"book-chapter","created":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T14:05:56Z","timestamp":1770386756000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The T Cell Response to Epstein-Barr Virus"],"prefix":"10.1007","author":[{"given":"Heather M.","family":"Long","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham S.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,7]]},"reference":[{"issue":"11","key":"339_CR1","doi-asserted-by":"crossref","first-page":"5398","DOI":"10.4049\/jimmunol.1301629","volume":"191","author":"RJ Abbott","year":"2013","unstructured":"Abbott RJ, Quinn LL, Leese AM, Scholes HM, Pachnio A, Rickinson AB (2013) CD8+ T cell responses to lytic EBV infection: late antigen specificities as subdominant components of the total response. J Immunol 191(11):5398\u20135409","journal-title":"J Immunol"},{"key":"339_CR2","doi-asserted-by":"crossref","unstructured":"Abbott RJ, Pachnio A, Pedroza-Pacheco I, Leese AM, Begum J, Long HM, Croom-Carter D, Stacey A, Moss PAH, Hislop AD, Borrow P, Rickinson AB, Bell AI (2017) Asymptomatic primary infection with Epstein-Barr virus: observations on Young adult cases. J Virol 91(21):e00382-17.","DOI":"10.1128\/JVI.00382-17"},{"issue":"7","key":"339_CR3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0000583","volume":"2","author":"D Adhikary","year":"2007","unstructured":"Adhikary D, Behrends U, Boerschmann H, Pfunder A, Burdach S, Moosmann A, Witter K, Bornkamm GW, Mautner J (2007) Immunodominance of lytic cycle antigens in Epstein-Barr virus-specific CD4+ T cell preparations for therapy. PLoS One 2(7):e583","journal-title":"PLoS One"},{"issue":"4\u20135","key":"339_CR4","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1177\/13524585241235825","volume":"30","author":"F Aloisi","year":"2024","unstructured":"Aloisi F, Salvetti M (2024) EBV infection drives MS pathology: yes. Mult Scler 30(4\u20135):483\u2013485","journal-title":"Mult Scler"},{"issue":"4","key":"339_CR5","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S1474-4422(22)00471-9","volume":"22","author":"F Aloisi","year":"2023","unstructured":"Aloisi F, Giovannoni G, Salvetti M (2023) Epstein-Barr virus as a cause of multiple sclerosis: opportunities for prevention and therapy. Lancet Neurol 22(4):338\u2013349","journal-title":"Lancet Neurol"},{"issue":"1","key":"339_CR6","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1038\/s41598-024-52666-4","volume":"14","author":"ME Amarillo","year":"2024","unstructured":"Amarillo ME, Moyano A, Ferressini Gerpe N, De Matteo E, Preciado MV, Chabay P (2024) Tonsillar cytotoxic CD4 T cells are involved in the control of EBV primary infection in children. Sci Rep 14(1):2135","journal-title":"Sci Rep"},{"issue":"6","key":"339_CR7","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1084\/jem.20022058","volume":"198","author":"E Amyes","year":"2003","unstructured":"Amyes E, Hatton C, Montamat-Sicotte D, Gudgeon N, Rickinson AB, McMichael AJ, Callan MF (2003) Characterization of the CD4+ T cell response to Epstein-Barr virus during primary and persistent infection. J Exp Med 198(6):903\u2013911","journal-title":"J Exp Med"},{"issue":"1","key":"339_CR8","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/s41375-018-0178-x","volume":"33","author":"E Anastasiadou","year":"2019","unstructured":"Anastasiadou E, Stroopinsky D, Alimperti S, Jiao AL, Pyzer AR, Cippitelli C, Pepe G, Severa M, Rosenblatt J, Etna MP, Rieger S, Kempkes B, Coccia EM, Sui SJH, Chen CS, Uccini S, Avigan D, Faggioni A, Trivedi P, Slack FJ (2019) Epstein-Barr virus-encoded EBNA2 alters immune checkpoint PD-L1 expression by downregulating miR-34a in B-cell lymphomas. Leukemia 33(1):132\u2013147","journal-title":"Leukemia"},{"issue":"4","key":"339_CR9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003220","volume":"9","author":"DF Angelini","year":"2013","unstructured":"Angelini DF, Serafini B, Piras E, Severa M, Coccia EM, Rosicarelli B, Ruggieri S, Gasperini C, Buttari F, Centonze D, Mechelli R, Salvetti M, Borsellino G, Aloisi F, Battistini L (2013) Increased CD8+ T cell response to Epstein-Barr virus lytic antigens in the active phase of multiple sclerosis. PLoS Pathog 9(4):e1003220","journal-title":"PLoS Pathog"},{"issue":"9","key":"339_CR10","doi-asserted-by":"crossref","first-page":"4831","DOI":"10.4049\/jimmunol.165.9.4831","volume":"165","author":"NE Annels","year":"2000","unstructured":"Annels NE, Callan MF, Tan L, Rickinson AB (2000) Changing patterns of dominant TCR usage with maturation of an EBV-specific cytotoxic T cell response. J Immunol 165(9):4831\u20134841","journal-title":"J Immunol"},{"issue":"11","key":"339_CR11","doi-asserted-by":"crossref","first-page":"5954","DOI":"10.4049\/jimmunol.168.11.5954","volume":"168","author":"V Appay","year":"2002","unstructured":"Appay V, Zaunders JJ, Papagno L, Sutton J, Jaramillo A, Waters A, Easterbrook P, Grey P, Smith D, McMichael AJ, Cooper DA, Rowland-Jones SL, Kelleher AD (2002) Characterization of CD4(+) CTLs ex vivo. J Immunol 168(11):5954\u20135958","journal-title":"J Immunol"},{"issue":"12","key":"339_CR12","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/s41577-022-00718-z","volume":"22","author":"KE Attfield","year":"2022","unstructured":"Attfield KE, Jensen LT, Kaufmann M, Friese MA, Fugger L (2022) The immunology of multiple sclerosis. Nat Rev Immunol 22(12):734\u2013750","journal-title":"Nat Rev Immunol"},{"issue":"16","key":"339_CR13","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1182\/blood-2014-01-553024","volume":"124","author":"T Azzi","year":"2014","unstructured":"Azzi T, Lunemann A, Murer A, Ueda S, Beziat V, Malmberg KJ, Staubli G, Gysin C, Berger C, Munz C, Chijioke O, Nadal D (2014) Role for early-differentiated natural killer cells in infectious mononucleosis. Blood 124(16):2533\u20132543","journal-title":"Blood"},{"key":"339_CR14","volume-title":"Infectious mononucleosis","author":"HH Balfour Jr","year":"2025","unstructured":"Balfour HH Jr, Meirhaeghe MR (2025) Infectious mononucleosis. Curr Top Microbiol Immunol"},{"issue":"8","key":"339_CR15","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1093\/infdis\/jit321","volume":"208","author":"HH Balfour Jr","year":"2013","unstructured":"Balfour HH Jr, Sifakis F, Sliman JA, Knight JA, Schmeling DO, Thomas W (2013) Age-specific prevalence of Epstein-Barr virus infection among individuals aged 6-19 years in the United States and factors affecting its acquisition. J Infect Dis 208(8):1286\u20131293","journal-title":"J Infect Dis"},{"key":"339_CR16","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1177\/13524585211044479","volume":"28","author":"A Bar-Or","year":"2022","unstructured":"Bar-Or A, Pender MP, Hodgkinson SJ, Broadley S, Lindsey JW, Ioannides ZA, Bagert B, Gamelin L, Liu E, Ye W (2022) Updated open-label extension clinical data and new magnetization transfer ratio imaging data from a phase I study of ATA188, an off-the-shelf, allogeneic Epstein-Barr virus-targeted T-cell immuno- therapy for progressive multiple sclerosis. Mult Scler J 28:72","journal-title":"Mult Scler J"},{"key":"339_CR17","doi-asserted-by":"crossref","first-page":"146","DOI":"10.3389\/fimmu.2019.00146","volume":"10","author":"MHM Barros","year":"2019","unstructured":"Barros MHM, Vera-Lozada G, Segges P, Hassan R, Niedobitek G (2019) Revisiting the tissue microenvironment of infectious mononucleosis: identification of EBV infection in T cells and deep characterization of immune profiles. Front Immunol 10:146","journal-title":"Front Immunol"},{"issue":"2","key":"339_CR18","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/bjh.19255","volume":"204","author":"K Bednarska","year":"2024","unstructured":"Bednarska K, Chowdhury R, Tobin JWD, Swain F, Keane C, Boyle S, Khanna R, Gandhi MK (2024) Epstein-Barr virus-associated lymphomas decoded. Br J Haematol 204(2):415\u2013433","journal-title":"Br J Haematol"},{"issue":"2","key":"339_CR19","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1006\/viro.1999.9996","volume":"264","author":"G Benninger-Doring","year":"1999","unstructured":"Benninger-Doring G, Pepperl S, Deml L, Modrow S, Wolf H, Jilg W (1999) Frequency of CD8(+) T lymphocytes specific for lytic and latent antigens of Epstein-Barr virus in healthy virus carriers. Virology 264(2):289\u2013297","journal-title":"Virology"},{"issue":"7","key":"339_CR20","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1002\/eji.200838023","volume":"38","author":"L Berthelot","year":"2008","unstructured":"Berthelot L, Laplaud DA, Pettre S, Ballet C, Michel L, Hillion S, Braudeau C, Connan F, Lefrere F, Wiertlewski S, Guillet JG, Brouard S, Choppin J, Soulillou JP (2008) Blood CD8+ T cell responses against myelin determinants in multiple sclerosis and healthy individuals. Eur J Immunol 38(7):1889\u20131899","journal-title":"Eur J Immunol"},{"issue":"6","key":"339_CR21","doi-asserted-by":"crossref","first-page":"3893","DOI":"10.4049\/jimmunol.172.6.3893","volume":"172","author":"B Bielekova","year":"2004","unstructured":"Bielekova B, Sung MH, Kadom N, Simon R, McFarland H, Martin R (2004) Expansion and functional relevance of high-avidity myelin-specific CD4+ T cells in multiple sclerosis. J Immunol 172(6):3893\u20133904","journal-title":"J Immunol"},{"issue":"7","key":"339_CR22","doi-asserted-by":"crossref","first-page":"4094","DOI":"10.4049\/jimmunol.176.7.4094","volume":"176","author":"F Bihl","year":"2006","unstructured":"Bihl F, Frahm N, Di Giammarino L, Sidney J, John M, Yusim K, Woodberry T, Sango K, Hewitt HS, Henry L, Linde CH, Chisholm JV 3rd, Zaman TM, Pae E, Mallal S, Walker BD, Sette A, Korber BT, Heckerman D, Brander C (2006) Impact of HLA-B alleles, epitope binding affinity, functional avidity, and viral coinfection on the immunodominance of virus-specific CTL responses. J Immunol 176(7):4094\u20134101","journal-title":"J Immunol"},{"issue":"6578","key":"339_CR23","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1126\/science.abj8222","volume":"375","author":"K Bjornevik","year":"2022","unstructured":"Bjornevik K, Cortese M, Healy BC, Kuhle J, Mina MJ, Leng Y, Elledge SJ, Niebuhr DW, Scher AI, Munger KL, Ascherio A (2022) Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis. Science 375(6578):296\u2013301","journal-title":"Science"},{"issue":"12","key":"339_CR24","doi-asserted-by":"crossref","first-page":"7078","DOI":"10.4049\/jimmunol.165.12.7078","volume":"165","author":"N Blake","year":"2000","unstructured":"Blake N, Haigh T, Shaka'a G, Croom-Carter D, Rickinson A (2000) The importance of exogenous antigen in priming the human CD8+ T cell response: lessons from the EBV nuclear antigen EBNA1. J Immunol 165(12):7078\u20137087","journal-title":"J Immunol"},{"issue":"Suppl 1","key":"339_CR25","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1016\/j.ijporl.2003.08.018","volume":"67","author":"P Brandtzaeg","year":"2003","unstructured":"Brandtzaeg P (2003) Immunology of tonsils and adenoids: everything the ENT surgeon needs to know. Int J Pediatr Otorhinolaryngol 67(Suppl 1):S69\u2013S76","journal-title":"Int J Pediatr Otorhinolaryngol"},{"issue":"4","key":"339_CR26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1010453","volume":"18","author":"JA Bristol","year":"2022","unstructured":"Bristol JA, Brand J, Ohashi M, Eichelberg MR, Casco A, Nelson SE, Hayes M, Romero-Masters JC, Baiu DC, Gumperz JE, Johannsen EC, Dinh HQ, Kenney SC (2022) Reduced IRF4 expression promotes lytic phenotype in type 2 EBV-infected B cells. PLoS Pathog 18(4):e1010453","journal-title":"PLoS Pathog"},{"issue":"17","key":"339_CR27","doi-asserted-by":"crossref","first-page":"eabn1823","DOI":"10.1126\/sciadv.abn1823","volume":"8","author":"M Bronge","year":"2022","unstructured":"Bronge M, Hogelin KA, Thomas OG, Ruhrmann S, Carvalho-Queiroz C, Nilsson OB, Kaiser A, Zeitelhofer M, Holmgren E, Linnerbauer M, Adzemovic MZ, Hellstrom C, Jelcic I, Liu H, Nilsson P, Hillert J, Brundin L, Fink K, Kockum I, Tengvall K, Martin R, Tegel H, Graslund T, Al Nimer F, Guerreiro-Cacais AO, Khademi M, Gafvelin G, Olsson T, Gronlund H (2022) Identification of four novel T cell autoantigens and personal autoreactive profiles in multiple sclerosis. Sci Adv 8(17):eabn1823","journal-title":"Sci Adv"},{"issue":"9","key":"339_CR28","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1084\/jem.187.9.1395","volume":"187","author":"MF Callan","year":"1998","unstructured":"Callan MF, Tan L, Annels N, Ogg GS, Wilson JD, O'Callaghan CA, Steven N, McMichael AJ, Rickinson AB (1998) Direct visualization of antigen-specific CD8+ T cells during the primary immune response to Epstein-Barr virus in vivo. J Exp Med 187(9):1395\u20131402","journal-title":"J Exp Med"},{"issue":"10","key":"339_CR29","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1172\/JCI10590","volume":"106","author":"MF Callan","year":"2000","unstructured":"Callan MF, Fazou C, Yang H, Rostron T, Poon K, Hatton C, McMichael AJ (2000) CD8(+) T-cell selection, function, and death in the primary immune response in vivo. J Clin Invest 106(10):1251\u20131261","journal-title":"J Clin Invest"},{"key":"339_CR30","doi-asserted-by":"crossref","first-page":"8795673","DOI":"10.1155\/2019\/8795673","volume":"2019","author":"C Capuano","year":"2019","unstructured":"Capuano C, Pighi C, Battella S, Santoni A, Palmieri G, Galandrini R (2019) Memory NK cell features exploitable in anticancer immunotherapy. J Immunol Res 2019:8795673","journal-title":"J Immunol Res"},{"issue":"1","key":"339_CR31","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/cei.12337","volume":"177","author":"D Cardenas Sierra","year":"2014","unstructured":"Cardenas Sierra D, Velez Colmenares G, Orfao de Matos A, Fiorentino Gomez S, Quijano Gomez SM (2014) Age-associated Epstein-Barr virus-specific T cell responses in seropositive healthy adults. Clin Exp Immunol 177(1):320\u2013332","journal-title":"Clin Exp Immunol"},{"issue":"8","key":"339_CR32","doi-asserted-by":"crossref","first-page":"4450","DOI":"10.4049\/jimmunol.167.8.4450","volume":"167","author":"MD Catalina","year":"2001","unstructured":"Catalina MD, Sullivan JL, Bak KR, Luzuriaga K (2001) Differential evolution and stability of epitope-specific CD8(+) T cell responses in EBV infection. J Immunol 167(8):4450\u20134457","journal-title":"J Immunol"},{"issue":"8","key":"339_CR33","doi-asserted-by":"crossref","first-page":"4184","DOI":"10.4049\/jimmunol.168.8.4184","volume":"168","author":"MD Catalina","year":"2002","unstructured":"Catalina MD, Sullivan JL, Brody RM, Luzuriaga K (2002) Phenotypic and functional heterogeneity of EBV epitope-specific CD8+ T cells. J Immunol 168(8):4184\u20134191","journal-title":"J Immunol"},{"issue":"4","key":"339_CR34","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/imm.12808","volume":"152","author":"MT Cencioni","year":"2017","unstructured":"Cencioni MT, Magliozzi R, Nicholas R, Ali R, Malik O, Reynolds R, Borsellino G, Battistini L, Muraro PA (2017) Programmed death 1 is highly expressed on CD8(+) CD57(+) T cells in patients with stable multiple sclerosis and inhibits their cytotoxic response to Epstein-Barr virus. Immunology 152(4):660\u2013676","journal-title":"Immunology"},{"issue":"5","key":"339_CR35","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1172\/JCI200523661","volume":"115","author":"S Cepok","year":"2005","unstructured":"Cepok S, Zhou D, Srivastava R, Nessler S, Stei S, Bussow K, Sommer N, Hemmer B (2005) Identification of Epstein-Barr virus proteins as putative targets of the immune response in multiple sclerosis. J Clin Invest 115(5):1352\u20131360","journal-title":"J Clin Invest"},{"issue":"16","key":"339_CR36","first-page":"6219","volume":"61","author":"AL Chapman","year":"2001","unstructured":"Chapman AL, Rickinson AB, Thomas WA, Jarrett RF, Crocker J, Lee SP (2001) Epstein-Barr virus-specific cytotoxic T lymphocyte responses in the blood and tumor site of Hodgkin's disease patients: implications for a T-cell-based therapy. Cancer Res 61(16):6219\u20136226","journal-title":"Cancer Res"},{"issue":"5","key":"339_CR37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007748","volume":"15","author":"B Chatterjee","year":"2019","unstructured":"Chatterjee B, Deng Y, Holler A, Nunez N, Azzi T, Vanoaica LD, Muller A, Zdimerova H, Antsiferova O, Zbinden A, Capaul R, Dreyer JH, Nadal D, Becher B, Robinson MD, Stauss H, Munz C (2019) CD8+ T cells retain protective functions despite sustained inhibitory receptor expression during Epstein-Barr virus infection in vivo. PLoS Pathog 15(5):e1007748","journal-title":"PLoS Pathog"},{"issue":"6","key":"339_CR38","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1111\/ijlh.14131","volume":"45","author":"B Chen","year":"2023","unstructured":"Chen B, Han N, Gao LY, Zhou TD, Zhang H, He P, Zhou Q (2023) Comparison of immune responses in children with infectious mononucleosis caused by Epstein-Barr virus at different infection stages. Int J Lab Hematol 45(6):890\u2013898","journal-title":"Int J Lab Hematol"},{"issue":"1","key":"339_CR39","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1146\/annurev-immunol-101320-020220","volume":"42","author":"SN Christo","year":"2024","unstructured":"Christo SN, Park SL, Mueller SN, Mackay LK (2024) The multifaceted role of tissue-resident memory T cells. Annu Rev Immunol 42(1):317\u2013345","journal-title":"Annu Rev Immunol"},{"issue":"15","key":"339_CR40","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1182\/blood-2013-01-480665","volume":"122","author":"BK Chung","year":"2013","unstructured":"Chung BK, Tsai K, Allan LL, Zheng DJ, Nie JC, Biggs CM, Hasan MR, Kozak FK, van den Elzen P, Priatel JJ, Tan R (2013) Innate immune control of EBV-infected B cells by invariant natural killer T cells. Blood 122(15):2600\u20132608","journal-title":"Blood"},{"issue":"6","key":"339_CR41","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1002\/eji.201646837","volume":"47","author":"D Cibrian","year":"2017","unstructured":"Cibrian D, Sanchez-Madrid F (2017) CD69: from activation marker to metabolic gatekeeper. Eur J Immunol 47(6):946\u2013953","journal-title":"Eur J Immunol"},{"issue":"4","key":"339_CR42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0094497","volume":"9","author":"CE Cocuzza","year":"2014","unstructured":"Cocuzza CE, Piazza F, Musumeci R, Oggioni D, Andreoni S, Gardinetti M, Fusco L, Frigo M, Banfi P, Rottoli MR, Confalonieri P, Rezzonico M, Ferro MT, Cavaletti G, E.-M.I.S. Group (2014) Quantitative detection of epstein-barr virus DNA in cerebrospinal fluid and blood samples of patients with relapsing-remitting multiple sclerosis. PLoS One 9(4):e94497","journal-title":"PLoS One"},{"issue":"1","key":"339_CR43","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/s41582-020-00427-y","volume":"17","author":"I Cortese","year":"2021","unstructured":"Cortese I, Reich DS, Nath A (2021) Progressive multifocal leukoencephalopathy and the spectrum of JC virus-related disease. Nat Rev Neurol 17(1):37\u201351","journal-title":"Nat Rev Neurol"},{"key":"339_CR44","doi-asserted-by":"publisher","unstructured":"Cortese M, Ascherio A, Bjornevik K (2025) EBV and autoimmunity. Curr Top Microbiol Immunol. https:\/\/doi.org\/10.1007\/82_2025_304","DOI":"10.1007\/82_2025_304"},{"key":"339_CR45","doi-asserted-by":"crossref","first-page":"1293090","DOI":"10.3389\/fimmu.2023.1293090","volume":"14","author":"B Couturaud","year":"2023","unstructured":"Couturaud B, Doix B, Carretero-Iglesia L, Allard M, Pradervand S, Hebeisen M, Rufer N (2023) Overall avidity declines in TCR repertoires during latent CMV but not EBV infection. Front Immunol 14:1293090","journal-title":"Front Immunol"},{"issue":"6","key":"339_CR46","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1177\/1352458518770019","volume":"25","author":"LE Creary","year":"2019","unstructured":"Creary LE, Mallempati KC, Gangavarapu S, Caillier SJ, Oksenberg JR, Fernandez-Vina MA (2019) Deconstruction of HLA-DRB1*04:01:01 and HLA-DRB1*15:01:01 class II haplotypes using next-generation sequencing in European-Americans with multiple sclerosis. Mult Scler 25(6):772\u2013782","journal-title":"Mult Scler"},{"key":"339_CR47","doi-asserted-by":"crossref","first-page":"14760","DOI":"10.1038\/ncomms14760","volume":"8","author":"MS Davey","year":"2017","unstructured":"Davey MS, Willcox CR, Joyce SP, Ladell K, Kasatskaya SA, McLaren JE, Hunter S, Salim M, Mohammed F, Price DA, Chudakov DM, Willcox BE (2017) Clonal selection in the human Vdelta1 T cell repertoire indicates gammadelta TCR-dependent adaptive immune surveillance. Nat Commun 8:14760","journal-title":"Nat Commun"},{"issue":"5","key":"339_CR48","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1093\/infdis\/161.5.1013","volume":"161","author":"P De Paoli","year":"1990","unstructured":"De Paoli P, Gennari D, Martelli P, Cavarzerani V, Comoretto R, Santini G (1990) Gamma delta T cell receptor-bearing lymphocytes during Epstein-Barr virus infection. J Infect Dis 161(5):1013\u20131016","journal-title":"J Infect Dis"},{"issue":"6","key":"339_CR49","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1084\/jem.20161017","volume":"214","author":"Z Djaoud","year":"2017","unstructured":"Djaoud Z, Guethlein LA, Horowitz A, Azzi T, Nemat-Gorgani N, Olive D, Nadal D, Norman PJ, Munz C, Parham P (2017) Two alternate strategies for innate immunity to Epstein-Barr virus: one using NK cells and the other NK cells and gammadelta T cells. J Exp Med 214(6):1827\u20131841","journal-title":"J Exp Med"},{"issue":"1","key":"339_CR50","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/cei.12339","volume":"177","author":"G Dolton","year":"2014","unstructured":"Dolton G, Lissina A, Skowera A, Ladell K, Tungatt K, Jones E, Kronenberg-Versteeg D, Akpovwa H, Pentier JM, Holland CJ, Godkin AJ, Cole DK, Neller MA, Miles JJ, Price DA, Peakman M, Sewell AK (2014) Comparison of peptide-major histocompatibility complex tetramers and dextramers for the identification of antigen-specific T cells. Clin Exp Immunol 177(1):47\u201363","journal-title":"Clin Exp Immunol"},{"issue":"12","key":"339_CR51","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1010137","volume":"17","author":"AC Dowell","year":"2021","unstructured":"Dowell AC, Haigh TA, Ryan GB, Turner JE, Long HM, Taylor GS (2021) Cytotoxic CD4+ T-cells specific for EBV capsid antigen BORF1 are maintained in long-term latently infected healthy donors. PLoS Pathog 17(12):e1010137","journal-title":"PLoS Pathog"},{"issue":"6","key":"339_CR52","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1086\/428097","volume":"191","author":"S Fafi-Kremer","year":"2005","unstructured":"Fafi-Kremer S, Morand P, Brion JP, Pavese P, Baccard M, Germi R, Genoulaz O, Nicod S, Jolivet M, Ruigrok RW, Stahl JP, Seigneurin JM (2005) Long-term shedding of infectious epstein-barr virus after infectious mononucleosis. J Infect Dis 191(6):985\u2013989","journal-title":"J Infect Dis"},{"issue":"23","key":"339_CR53","doi-asserted-by":"crossref","first-page":"12189","DOI":"10.18632\/oncotarget.2608","volume":"5","author":"W Fang","year":"2014","unstructured":"Fang W, Zhang J, Hong S, Zhan J, Chen N, Qin T, Tang Y, Zhang Y, Kang S, Zhou T, Wu X, Liang W, Hu Z, Ma Y, Zhao Y, Tian Y, Yang Y, Xue C, Yan Y, Hou X, Huang P, Huang Y, Zhao H, Zhang L (2014) EBV-driven LMP1 and IFN-gamma up-regulate PD-L1 in nasopharyngeal carcinoma: implications for oncotargeted therapy. Oncotarget 5(23):12189\u201312202","journal-title":"Oncotarget"},{"issue":"11","key":"339_CR54","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1038\/bmt.2013.75","volume":"48","author":"L Farnault","year":"2013","unstructured":"Farnault L, Gertner-Dardenne J, Gondois-Rey F, Michel G, Chambost H, Hirsch I, Olive D (2013) Clinical evidence implicating gamma-delta T cells in EBV control following cord blood transplantation. Bone Marrow Transplant 48(11):1478\u20131479","journal-title":"Bone Marrow Transplant"},{"issue":"9","key":"339_CR55","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007110","volume":"14","author":"C Forrest","year":"2018","unstructured":"Forrest C, Hislop AD, Rickinson AB, Zuo J (2018) Proteome-wide analysis of CD8+ T cell responses to EBV reveals differences between primary and persistent infection. PLoS Pathog 14(9):e1007110","journal-title":"PLoS Pathog"},{"issue":"1","key":"339_CR56","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/j.1365-2249.2007.03388.x","volume":"149","author":"N Fujishima","year":"2007","unstructured":"Fujishima N, Hirokawa M, Fujishima M, Yamashita J, Saitoh H, Ichikawa Y, Horiuchi T, Kawabata Y, Sawada KI (2007) Skewed T cell receptor repertoire of Vdelta1(+) gammadelta T lymphocytes after human allogeneic haematopoietic stem cell transplantation and the potential role for Epstein-Barr virus-infected B cells in clonal restriction. Clin Exp Immunol 149(1):70\u201379","journal-title":"Clin Exp Immunol"},{"issue":"4","key":"339_CR57","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1002\/1521-4141(200204)32:4<936::AID-IMMU936>3.0.CO;2-M","volume":"32","author":"P Garcia","year":"2002","unstructured":"Garcia P, Llano M, de Heredia AB, Willberg CB, Caparros E, Aparicio P, Braud VM, Lopez-Botet M (2002) Human T cell receptor-mediated recognition of HLA-E. Eur J Immunol 32(4):936\u2013944","journal-title":"Eur J Immunol"},{"issue":"1","key":"339_CR58","doi-asserted-by":"crossref","DOI":"10.1111\/imr.13434","volume":"329","author":"GM Gillespie","year":"2025","unstructured":"Gillespie GM, Quastel MN, McMichael AJ (2025) HLA-E: immune receptor functional mechanisms revealed by structural studies. Immunol Rev 329(1):e13434","journal-title":"Immunol Rev"},{"key":"339_CR59","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2023.105364","volume":"81","author":"G Giovannoni","year":"2024","unstructured":"Giovannoni G, Hawkes CH, Lechner-Scott J, Levy M, Yeh EA (2024) Emboldened or not: the potential fall-out of a failed anti-EBV trial in multiple sclerosis. Mult Scler Relat Disord 81:105364","journal-title":"Mult Scler Relat Disord"},{"issue":"9","key":"339_CR60","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.1093\/brain\/awaf170","volume":"148","author":"G Giovannoni","year":"2025","unstructured":"Giovannoni G, James L, Adeniran AA, Gold J, Young LS, Selwood DL, Baker D, Dobson R (2025) The case for targeting latent and lytic Epstein-Barr virus infection in multiple sclerosis. Brain 148(9):3057\u20133071","journal-title":"Brain"},{"issue":"3","key":"339_CR61","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2315857121","volume":"121","author":"A Gottlieb","year":"2024","unstructured":"Gottlieb A, Pham HPT, Saltarrelli JG, Lindsey JW (2024) Expanded T lymphocytes in the cerebrospinal fluid of multiple sclerosis patients are specific for Epstein-Barr-virus-infected B cells. Proc Natl Acad Sci USA 121(3):e2315857121","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"339_CR62","doi-asserted-by":"crossref","first-page":"433","DOI":"10.4161\/viru.25780","volume":"4","author":"U Gowthaman","year":"2013","unstructured":"Gowthaman U, Eswarakumar VP (2013) Molecular mimicry: good artists copy, great artists steal. Virulence 4(6):433\u2013434","journal-title":"Virulence"},{"key":"339_CR63","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1146\/annurev-immunol-093019-112809","volume":"40","author":"JI Gray","year":"2022","unstructured":"Gray JI, Farber DL (2022) Tissue-Resident Immune Cells in Humans. Annu Rev Immunol 40:195\u2013220","journal-title":"Annu Rev Immunol"},{"issue":"1","key":"339_CR64","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0198-8859(96)00241-8","volume":"52","author":"C Grimsley","year":"1997","unstructured":"Grimsley C, Ober C (1997) Population genetic studies of HLA-E: evidence for selection. Hum Immunol 52(1):33\u201340","journal-title":"Hum Immunol"},{"issue":"9","key":"339_CR65","doi-asserted-by":"crossref","first-page":"5477","DOI":"10.1128\/JVI.79.9.5477-5488.2005","volume":"79","author":"NH Gudgeon","year":"2005","unstructured":"Gudgeon NH, Taylor GS, Long HM, Haigh TA, Rickinson AB (2005) Regression of Epstein-Barr virus-induced B-cell transformation in vitro involves virus-specific CD8+ T cells as the principal effectors and a novel CD4+ T-cell reactivity. J Virol 79(9):5477\u20135488","journal-title":"J Virol"},{"issue":"12","key":"339_CR66","doi-asserted-by":"crossref","first-page":"3984","DOI":"10.4049\/jimmunol.149.12.3984","volume":"149","author":"G Hacker","year":"1992","unstructured":"Hacker G, Kromer S, Falk M, Heeg K, Wagner H, Pfeffer K (1992) V delta 1+ subset of human gamma delta T cells responds to ligands expressed by EBV-infected Burkitt lymphoma cells and transformed B lymphocytes. J Immunol 149(12):3984\u20133989","journal-title":"J Immunol"},{"issue":"1","key":"339_CR67","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jid.2017.05.026","volume":"138","author":"JB Hardenberg","year":"2018","unstructured":"Hardenberg JB, Braun A, Schon MP (2018) A Yin and Yang in epithelial immunology: the roles of the alpha(E)(CD103)beta(7) integrin in T cells. J Invest Dermatol 138(1):23\u201331","journal-title":"J Invest Dermatol"},{"issue":"2","key":"339_CR68","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1365-2141.1991.tb07990.x","volume":"77","author":"J Hassan","year":"1991","unstructured":"Hassan J, Feighery C, Bresnihan B, Whelan A (1991) Elevated T cell receptor gamma delta + T cells in patients with infectious mononucleosis. Br J Haematol 77(2):255\u2013256","journal-title":"Br J Haematol"},{"key":"339_CR69","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.876493","volume":"13","author":"T Herrmann","year":"2022","unstructured":"Herrmann T, Karunakaran MM (2022) Butyrophilins: gammadelta T cell receptor ligands, immunomodulators and more. Front Immunol 13:876493","journal-title":"Front Immunol"},{"issue":"4","key":"339_CR70","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.4049\/jimmunol.167.4.2019","volume":"167","author":"AD Hislop","year":"2001","unstructured":"Hislop AD, Gudgeon NH, Callan MF, Fazou C, Hasegawa H, Salmon M, Rickinson AB (2001) EBV-specific CD8+ T cell memory: relationships between epitope specificity, cell phenotype, and immediate effector function. J Immunol 167(4):2019\u20132029","journal-title":"J Immunol"},{"issue":"7","key":"339_CR71","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1084\/jem.20011692","volume":"195","author":"AD Hislop","year":"2002","unstructured":"Hislop AD, Annels NE, Gudgeon NH, Leese AM, Rickinson AB (2002) Epitope-specific evolution of human CD8(+) T cell responses from primary to persistent phases of Epstein-Barr virus infection. J Exp Med 195(7):893\u2013905","journal-title":"J Exp Med"},{"issue":"9","key":"339_CR72","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1172\/JCI24810","volume":"115","author":"AD Hislop","year":"2005","unstructured":"Hislop AD, Kuo M, Drake-Lee AB, Akbar AN, Bergler W, Hammerschmitt N, Khan N, Palendira U, Leese AM, Timms JM, Bell AI, Buckley CD, Rickinson AB (2005) Tonsillar homing of Epstein-Barr virus-specific CD8+ T cells and the virus-host balance. J Clin Invest 115(9):2546\u20132555","journal-title":"J Clin Invest"},{"key":"339_CR73","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1146\/annurev.immunol.25.022106.141553","volume":"25","author":"AD Hislop","year":"2007","unstructured":"Hislop AD, Taylor GS, Sauce D, Rickinson AB (2007) Cellular responses to viral infection in humans: lessons from Epstein-Barr virus. Annu Rev Immunol 25:587\u2013617","journal-title":"Annu Rev Immunol"},{"issue":"14","key":"339_CR74","doi-asserted-by":"crossref","first-page":"6400","DOI":"10.1073\/pnas.0915054107","volume":"107","author":"H Hjalgrim","year":"2010","unstructured":"Hjalgrim H, Rostgaard K, Johnson PC, Lake A, Shield L, Little AM, Ekstrom-Smedby K, Adami HO, Glimelius B, Hamilton-Dutoit S, Kane E, Taylor GM, McConnachie A, Ryder LP, Sundstrom C, Andersen PS, Chang ET, Alexander FE, Melbye M, Jarrett RF (2010) HLA-A alleles and infectious mononucleosis suggest a critical role for cytotoxic T-cell response in EBV-related Hodgkin lymphoma. Proc Natl Acad Sci USA 107(14):6400\u20136405","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"339_CR75","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/ni1312","volume":"7","author":"HL Hoare","year":"2006","unstructured":"Hoare HL, Sullivan LC, Pietra G, Clements CS, Lee EJ, Ely LK, Beddoe T, Falco M, Kjer-Nielsen L, Reid HH, McCluskey J, Moretta L, Rossjohn J, Brooks AG (2006) Structural basis for a major histocompatibility complex class Ib-restricted T cell response. Nat Immunol 7(3):256\u2013264","journal-title":"Nat Immunol"},{"issue":"1","key":"339_CR76","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1046\/j.1365-2249.2003.02114.x","volume":"132","author":"P Hollsberg","year":"2003","unstructured":"Hollsberg P, Hansen HJ, Haahr S (2003) Altered CD8+ T cell responses to selected Epstein-Barr virus immunodominant epitopes in patients with multiple sclerosis. Clin Exp Immunol 132(1):137\u2013143","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"339_CR77","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1080\/13550280490261671","volume":"10","author":"T Holmoy","year":"2004","unstructured":"Holmoy T, Vartdal F (2004) Cerebrospinal fluid T cells from multiple sclerosis patients recognize autologous Epstein-Barr virus-transformed B cells. J Neurovirol 10(1):52\u201356","journal-title":"J Neurovirol"},{"issue":"5","key":"339_CR78","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1080\/13550280490499524","volume":"10","author":"T Holmoy","year":"2004","unstructured":"Holmoy T, Kvale EO, Vartdal F (2004) Cerebrospinal fluid CD4+ T cells from a multiple sclerosis patient cross-recognize Epstein-Barr virus and myelin basic protein. J Neurovirol 10(5):278\u2013283","journal-title":"J Neurovirol"},{"issue":"3","key":"339_CR79","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.jcv.2010.11.017","volume":"50","author":"Y Hoshino","year":"2011","unstructured":"Hoshino Y, Nishikawa K, Ito Y, Kuzushima K, Kimura H (2011) Kinetics of Epstein-Barr virus load and virus-specific CD8+ T cells in acute infectious mononucleosis. J Clin Virol 50(3):244\u2013246","journal-title":"J Clin Virol"},{"issue":"7","key":"339_CR80","volume":"7","author":"X Huang","year":"2012","unstructured":"Huang X, Kushekhar K, Nolte I, Kooistra W, Visser L, Bouwman I, Kouprie N, Veenstra R, van Imhoff G, Olver B, Houlston RS, Poppema S, Diepstra A, Hepkema B, van den Berg A (2012) HLA associations in classical Hodgkin lymphoma: EBV status matters. PLoS One 7(7):e39986","journal-title":"PLoS One"},{"issue":"10","key":"339_CR81","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1093\/brain\/awae110","volume":"147","author":"J Huang","year":"2024","unstructured":"Huang J, Tengvall K, Lima IB, Hedstrom AK, Butt J, Brenner N, Gyllenberg A, Stridh P, Khademi M, Ernberg I, Al Nimer F, Manouchehrinia A, Hillert J, Alfredsson L, Andersen O, Sundstrom P, Waterboer T, Olsson T, Kockum I (2024) Genetics of immune response to Epstein-Barr virus: prospects for multiple sclerosis pathogenesis. Brain 147(10):3573\u20133582","journal-title":"Brain"},{"issue":"4","key":"339_CR82","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/modpathol.3800369","volume":"18","author":"SD Hudnall","year":"2005","unstructured":"Hudnall SD, Ge Y, Wei L, Yang NP, Wang HQ, Chen T (2005) Distribution and phenotype of Epstein-Barr virus-infected cells in human pharyngeal tonsils. Mod Pathol 18(4):519\u2013527","journal-title":"Mod Pathol"},{"issue":"1","key":"339_CR83","doi-asserted-by":"crossref","first-page":"319","DOI":"10.4049\/jimmunol.0803647","volume":"183","author":"EM Iancu","year":"2009","unstructured":"Iancu EM, Corthesy P, Baumgaertner P, Devevre E, Voelter V, Romero P, Speiser DE, Rufer N (2009) Clonotype selection and composition of human CD8 T cells specific for persistent herpes viruses varies with differentiation but is stable over time. J Immunol 183(1):319\u2013331","journal-title":"J Immunol"},{"key":"339_CR84","unstructured":"International Multiple Sclerosis Genetics Consortium (2019) Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility. Science 365(6460):eaav7188."},{"key":"339_CR85","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.652811","volume":"12","author":"ZA Ioannides","year":"2021","unstructured":"Ioannides ZA, Csurhes PA, Douglas NL, Mackenroth G, Swayne A, Thompson KM, Hopkins TJ, Green KA, Blum S, Hooper KD, Wyssusek KH, Coulthard A, Pender MP (2021) Sustained clinical improvement in a subset of patients with progressive multiple sclerosis treated with Epstein-Barr virus-specific T cell therapy. Front Neurol 12:652811","journal-title":"Front Neurol"},{"issue":"3","key":"339_CR86","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1002\/eji.200939761","volume":"40","author":"E Jaquiery","year":"2010","unstructured":"Jaquiery E, Jilek S, Schluep M, Meylan P, Lysandropoulos A, Pantaleo G, Du Pasquier RA (2010) Intrathecal immune responses to EBV in early MS. Eur J Immunol 40(3):878\u2013887","journal-title":"Eur J Immunol"},{"issue":"3","key":"339_CR87","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004746","volume":"11","author":"S Jayasooriya","year":"2015","unstructured":"Jayasooriya S, de Silva TI, Njie-jobe J, Sanyang C, Leese AM, Bell AI, McAulay KA, Yanchun P, Long HM, Dong T, Whittle HC, Rickinson AB, Rowland-Jones SL, Hislop AD, Flanagan KL (2015) Early virological and immunological events in asymptomatic Epstein-Barr virus infection in African children. PLoS Pathog 11(3):e1004746","journal-title":"PLoS Pathog"},{"issue":"Pt 7","key":"339_CR88","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1093\/brain\/awn108","volume":"131","author":"S Jilek","year":"2008","unstructured":"Jilek S, Schluep M, Meylan P, Vingerhoets F, Guignard L, Monney A, Kleeberg J, Le Goff G, Pantaleo G, Du Pasquier RA (2008) Strong EBV-specific CD8+ T-cell response in patients with early multiple sclerosis. Brain 131(Pt 7):1712\u20131721","journal-title":"Brain"},{"issue":"4","key":"339_CR89","first-page":"325","volume":"95","author":"D Jons","year":"2024","unstructured":"Jons D, Grut V, Bergstrom T, Zetterberg H, Bistrom M, Gunnarsson M, Vrethem M, Brenner N, Butt J, Blennow K, Nilsson S, Kockum I, Olsson T, Waterboer T, Sundstrom P, Andersen O (2024) Seroreactivity against lytic, latent and possible cross-reactive EBV antigens appears on average 10 years before MS induced preclinical neuroaxonal damage. J Neurol Neurosurg Psychiatry 95(4):325\u2013332","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"339_CR90","doi-asserted-by":"crossref","first-page":"2695396","DOI":"10.1155\/2016\/2695396","volume":"2016","author":"SA Joosten","year":"2016","unstructured":"Joosten SA, Sullivan LC, Ottenhoff TH (2016) Characteristics of HLA-E restricted T-cell responses and their role in infectious diseases. J Immunol Res 2016:2695396","journal-title":"J Immunol Res"},{"issue":"9","key":"339_CR91","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0046120","volume":"7","author":"PB Jorgensen","year":"2012","unstructured":"Jorgensen PB, Livbjerg AH, Hansen HJ, Petersen T, Hollsberg P (2012) Epstein-Barr virus peptide presented by HLA-E is predominantly recognized by CD8(bright) cells in multiple sclerosis patients. PLoS One 7(9):e46120","journal-title":"PLoS One"},{"issue":"3","key":"339_CR92","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000341","volume":"5","author":"GL Kelly","year":"2009","unstructured":"Kelly GL, Long HM, Stylianou J, Thomas WA, Leese A, Bell AI, Bornkamm GW, Mautner J, Rickinson AB, Rowe M (2009) An Epstein-Barr virus anti-apoptotic protein constitutively expressed in transformed cells and implicated in burkitt lymphomagenesis: the Wp\/BHRF1 link. PLoS Pathog 5(3):e1000341","journal-title":"PLoS Pathog"},{"issue":"12","key":"339_CR93","doi-asserted-by":"crossref","first-page":"7481","DOI":"10.4049\/jimmunol.173.12.7481","volume":"173","author":"N Khan","year":"2004","unstructured":"Khan N, Hislop A, Gudgeon N, Cobbold M, Khanna R, Nayak L, Rickinson AB, Moss PA (2004) Herpesvirus-specific CD8 T cell immunity in old age: cytomegalovirus impairs the response to a coresident EBV infection. J Immunol 173(12):7481\u20137489","journal-title":"J Immunol"},{"issue":"9","key":"339_CR94","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002889","volume":"8","author":"PL Klarenbeek","year":"2012","unstructured":"Klarenbeek PL, Remmerswaal EB, ten Berge IJ, Doorenspleet ME, van Schaik BD, Esveldt RE, Koch SD, ten Brinke A, van Kampen AH, Bemelman FJ, Tak PP, Baas F, de Vries N, van Lier RA (2012) Deep sequencing of antiviral T-cell responses to HCMV and EBV in humans reveals a stable repertoire that is maintained for many years. PLoS Pathog 8(9):e1002889","journal-title":"PLoS Pathog"},{"issue":"8","key":"339_CR95","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.00740-25","volume":"13","author":"E Koech","year":"2025","unstructured":"Koech E, Ogolla S, Amolo AS, Waomba K, Onditi I, Sabourin KR, Ariera B, Chumbe S, Kenney SC, Rochford R, Samayoa-Reyes G (2025) Epstein-Barr virus type 2 infection is associated with higher viral loads in pediatric tonsils from western Kenya. Microbiol Spectr 13(8):e0074025","journal-title":"Microbiol Spectr"},{"issue":"4","key":"339_CR96","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S1074-7613(00)00048-0","volume":"13","author":"J Kurth","year":"2000","unstructured":"Kurth J, Spieker T, Wustrow J, Strickler GJ, Hansmann LM, Rajewsky K, Kuppers R (2000) EBV-infected B cells in infectious mononucleosis: viral strategies for spreading in the B cell compartment and establishing latency. Immunity 13(4):485\u2013495","journal-title":"Immunity"},{"issue":"5","key":"339_CR97","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S1074-7613(02)00318-7","volume":"16","author":"LL Laichalk","year":"2002","unstructured":"Laichalk LL, Hochberg D, Babcock GJ, Freeman RB, Thorley-Lawson DA (2002) The dispersal of mucosal memory B cells: evidence from persistent EBV infection. Immunity 16(5):745\u2013754","journal-title":"Immunity"},{"key":"339_CR98","doi-asserted-by":"crossref","first-page":"416","DOI":"10.3389\/fmicb.2018.00416","volume":"9","author":"JKP Lam","year":"2018","unstructured":"Lam JKP, Hui KF, Ning RJ, Xu XQ, Chan KH, Chiang AKS (2018) Emergence of CD4+ and CD8+ Polyfunctional T cell responses against Immunodominant lytic and latent EBV antigens in children with primary EBV infection. Front Microbiol 9:416","journal-title":"Front Microbiol"},{"issue":"3","key":"339_CR99","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.4049\/jimmunol.177.3.1427","volume":"177","author":"E Landais","year":"2006","unstructured":"Landais E, Morice A, Long HM, Haigh TA, Charreau B, Bonneville M, Taylor GS, Houssaint E (2006) EBV-specific CD4+ T cell clones exhibit vigorous allogeneic responses. J Immunol 177(3):1427\u20131433","journal-title":"J Immunol"},{"key":"339_CR100","doi-asserted-by":"crossref","DOI":"10.3389\/fragi.2021.665637","volume":"2","author":"J Lanfermeijer","year":"2021","unstructured":"Lanfermeijer J, de Greef PC, Hendriks M, Vos M, van Beek J, Borghans JAM, van Baarle D (2021) Age and CMV-infection jointly affect the EBV-specific CD8(+) T-cell repertoire. Front Aging 2:665637","journal-title":"Front Aging"},{"issue":"10","key":"339_CR101","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1038\/ni835","volume":"3","author":"HL Lang","year":"2002","unstructured":"Lang HL, Jacobsen H, Ikemizu S, Andersson C, Harlos K, Madsen L, Hjorth P, Sondergaard L, Svejgaard A, Wucherpfennig K, Stuart DI, Bell JI, Jones EY, Fugger L (2002) A functional and structural basis for TCR cross-reactivity in multiple sclerosis. Nat Immunol 3(10):940\u2013943","journal-title":"Nat Immunol"},{"issue":"Pt 9","key":"339_CR102","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.1093\/brain\/awr197","volume":"134","author":"H Lassmann","year":"2011","unstructured":"Lassmann H, Niedobitek G, Aloisi F, Middeldorp JM, NeuroproMiSe EBVWG (2011) Epstein-Barr virus in the multiple sclerosis brain: a controversial issue\u2013report on a focused workshop held in the Centre for Brain Research of the Medical University of Vienna, Austria. Brain 134(Pt 9):2772\u20132786","journal-title":"Brain"},{"issue":"1","key":"339_CR103","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/ane.12417","volume":"133","author":"LB Latham","year":"2016","unstructured":"Latham LB, Lee MJ, Lincoln JA, Ji N, Forsthuber TG, Lindsey JW (2016) Antivirus immune activity in multiple sclerosis correlates with MRI activity. Acta Neurol Scand 133(1):17\u201324","journal-title":"Acta Neurol Scand"},{"issue":"4","key":"339_CR104","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1128\/JVI.77.4.2757-2761.2003","volume":"77","author":"G Lautscham","year":"2003","unstructured":"Lautscham G, Haigh T, Mayrhofer S, Taylor G, Croom-Carter D, Leese A, Gadola S, Cerundolo V, Rickinson A, Blake N (2003) Identification of a TAP-independent, immunoproteasome-dependent CD8+ T-cell epitope in Epstein-Barr virus latent membrane protein 2. J Virol 77(4):2757\u20132761","journal-title":"J Virol"},{"issue":"1","key":"339_CR105","doi-asserted-by":"crossref","first-page":"573","DOI":"10.4049\/jimmunol.165.1.573","volume":"165","author":"SP Lee","year":"2000","unstructured":"Lee SP, Chan AT, Cheung ST, Thomas WA, CroomCarter D, Dawson CW, Tsai CH, Leung SF, Johnson PJ, Huang DP (2000) CTL control of EBV in nasopharyngeal carcinoma (NPC): EBV-specific CTL responses in the blood and tumors of NPC patients and the antigen-processing function of the tumor cells. J Immunol 165(1):573\u2013582","journal-title":"J Immunol"},{"issue":"3","key":"339_CR106","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200226","volume":"11","author":"J Lehikoinen","year":"2024","unstructured":"Lehikoinen J, Nurmi K, Ainola M, Clancy J, Nieminen JK, Jansson L, Vauhkonen H, Vaheri A, Smura T, Laakso SM, Eklund KK, Tienari PJ (2024) Epstein-Barr virus in the cerebrospinal fluid and blood compartments of patients with multiple sclerosis and controls. Neurol Neuroimmunol Neuroinflamm 11(3):e200226","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"12","key":"339_CR107","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003076","volume":"8","author":"A Lelic","year":"2012","unstructured":"Lelic A, Verschoor CP, Ventresca M, Parsons R, Evelegh C, Bowdish D, Betts MR, Loeb MB, Bramson JL (2012) The polyfunctionality of human memory CD8+ T cells elicited by acute and chronic virus infections is not influenced by age. PLoS Pathog 8(12):e1003076","journal-title":"PLoS Pathog"},{"issue":"5","key":"339_CR108","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1073\/pnas.0909448107","volume":"107","author":"CS Leung","year":"2010","unstructured":"Leung CS, Haigh TA, Mackay LK, Rickinson AB, Taylor GS (2010) Nuclear location of an endogenously expressed antigen, EBNA1, restricts access to macroautophagy and the range of CD4 epitope display. Proc Natl Acad Sci USA 107(5):2165\u20132170","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7","key":"339_CR109","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.70491","volume":"97","author":"D Liang","year":"2025","unstructured":"Liang D, Wang H, Jin Y, Huang A, Yu M, Ye W, Hu X, Xia X, Jiang Y, Xu Z (2025) Unveiling the immune landscape: single-cell sequencing of infectious mononucleosis patients. J Med Virol 97(7):e70491","journal-title":"J Med Virol"},{"issue":"2","key":"339_CR110","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1177\/1352458508097920","volume":"15","author":"JW Lindsey","year":"2009","unstructured":"Lindsey JW, Hatfield LM, Crawford MP, Patel S (2009) Quantitative PCR for Epstein-Barr virus DNA and RNA in multiple sclerosis. Mult Scler 15(2):153\u2013158","journal-title":"Mult Scler"},{"issue":"5","key":"339_CR111","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0036779","volume":"7","author":"J Link","year":"2012","unstructured":"Link J, Kockum I, Lorentzen AR, Lie BA, Celius EG, Westerlind H, Schaffer M, Alfredsson L, Olsson T, Brynedal B, Harbo HF, Hillert J (2012) Importance of human leukocyte antigen (HLA) class I and II alleles on the risk of multiple sclerosis. PLoS One 7(5):e36779","journal-title":"PLoS One"},{"issue":"5","key":"339_CR112","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004068","volume":"10","author":"S Linnerbauer","year":"2014","unstructured":"Linnerbauer S, Behrends U, Adhikary D, Witter K, Bornkamm GW, Mautner J (2014) Virus and autoantigen-specific CD4+ T cells are key effectors in a SCID mouse model of EBV-associated post-transplant lymphoproliferative disorders. PLoS Pathog 10(5):e1004068","journal-title":"PLoS Pathog"},{"issue":"8","key":"339_CR113","doi-asserted-by":"crossref","first-page":"4896","DOI":"10.1128\/JVI.79.8.4896-4907.2005","volume":"79","author":"HM Long","year":"2005","unstructured":"Long HM, Haigh TA, Gudgeon NH, Leen AM, Tsang CW, Brooks J, Landais E, Houssaint E, Lee SP, Rickinson AB, Taylor GS (2005) CD4+ T-cell responses to Epstein-Barr virus (EBV) latent-cycle antigens and the recognition of EBV-transformed lymphoblastoid cell lines. J Virol 79(8):4896\u20134907","journal-title":"J Virol"},{"issue":"4","key":"339_CR114","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1182\/blood-2008-12-194043","volume":"114","author":"HM Long","year":"2009","unstructured":"Long HM, Zuo J, Leese AM, Gudgeon NH, Jia H, Taylor GS, Rickinson AB (2009) CD4+ T-cell clones recognizing human lymphoma-associated antigens: generation by in vitro stimulation with autologous Epstein-Barr virus-transformed B cells. Blood 114(4):807\u2013815","journal-title":"Blood"},{"issue":"1","key":"339_CR115","doi-asserted-by":"crossref","first-page":"92","DOI":"10.4049\/jimmunol.1100590","volume":"187","author":"HM Long","year":"2011","unstructured":"Long HM, Leese AM, Chagoury OL, Connerty SR, Quarcoopome J, Quinn LL, Shannon-Lowe C, Rickinson AB (2011) Cytotoxic CD4+ T cell responses to EBV contrast with CD8 responses in breadth of lytic cycle antigen choice and in lytic cycle recognition. J Immunol 187(1):92\u2013101","journal-title":"J Immunol"},{"issue":"5","key":"339_CR116","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1084\/jem.20121437","volume":"210","author":"HM Long","year":"2013","unstructured":"Long HM, Chagoury OL, Leese AM, Ryan GB, James E, Morton LT, Abbott RJ, Sabbah S, Kwok W, Rickinson AB (2013) MHC II tetramers visualize human CD4+ T cell responses to Epstein-Barr virus infection and demonstrate atypical kinetics of the nuclear antigen EBNA1 response. J Exp Med 210(5):933\u2013949","journal-title":"J Exp Med"},{"key":"339_CR117","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.3389\/fimmu.2019.02193","volume":"10","author":"HM Long","year":"2019","unstructured":"Long HM, Meckiff BJ, Taylor GS (2019) The T-cell response to Epstein-Barr virus-new tricks from an old dog. Front Immunol 10:2193","journal-title":"Front Immunol"},{"key":"339_CR118","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jneuroim.2011.09.011","volume":"240\u2013241","author":"A Lossius","year":"2011","unstructured":"Lossius A, Vartdal F, Holmoy T (2011) Vitamin D sensitive EBNA-1 specific T cells in the cerebrospinal fluid of patients with multiple sclerosis. J Neuroimmunol 240\u2013241:87\u201396","journal-title":"J Neuroimmunol"},{"issue":"11","key":"339_CR119","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1002\/eji.201444662","volume":"44","author":"A Lossius","year":"2014","unstructured":"Lossius A, Johansen JN, Vartdal F, Robins H, Jurate Saltyte B, Holmoy T, Olweus J (2014) High-throughput sequencing of TCR repertoires in multiple sclerosis reveals intrathecal enrichment of EBV-reactive CD8+ T cells. Eur J Immunol 44(11):3439\u20133452","journal-title":"Eur J Immunol"},{"issue":"3","key":"339_CR120","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1212\/WNL.0000000000000560","volume":"83","author":"FD Lublin","year":"2014","unstructured":"Lublin FD, Reingold SC, Cohen JA, Cutter GR, Sorensen PS, Thompson AJ, Wolinsky JS, Balcer LJ, Banwell B, Barkhof F, Bebo B Jr, Calabresi PA, Clanet M, Comi G, Fox RJ, Freedman MS, Goodman AD, Inglese M, Kappos L, Kieseier BC, Lincoln JA, Lubetzki C, Miller AE, Montalban X, O'Connor PW, Petkau J, Pozzilli C, Rudick RA, Sormani MP, Stuve O, Waubant E, Polman CH (2014) Defining the clinical course of multiple sclerosis: the 2013 revisions. Neurology 83(3):278\u2013286","journal-title":"Neurology"},{"issue":"Pt 6","key":"339_CR121","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1093\/brain\/awl067","volume":"129","author":"JD Lunemann","year":"2006","unstructured":"Lunemann JD, Edwards N, Muraro PA, Hayashi S, Cohen JI, Munz C, Martin R (2006) Increased frequency and broadened specificity of latent EBV nuclear antigen-1-specific T cells in multiple sclerosis. Brain 129(Pt 6):1493\u20131506","journal-title":"Brain"},{"issue":"8","key":"339_CR122","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1084\/jem.20072397","volume":"205","author":"JD Lunemann","year":"2008","unstructured":"Lunemann JD, Jelcic I, Roberts S, Lutterotti A, Tackenberg B, Martin R, Munz C (2008) EBNA1-specific T cells from patients with multiple sclerosis cross react with myelin antigens and co-produce IFN-gamma and IL-2. J Exp Med 205(8):1763\u20131773","journal-title":"J Exp Med"},{"issue":"1","key":"339_CR123","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/NEN.0b013e31827bfc62","volume":"72","author":"R Magliozzi","year":"2013","unstructured":"Magliozzi R, Serafini B, Rosicarelli B, Chiappetta G, Veroni C, Reynolds R, Aloisi F (2013) B-cell enrichment and Epstein-Barr virus infection in inflammatory cortical lesions in secondary progressive multiple sclerosis. J Neuropathol Exp Neurol 72(1):29\u201341","journal-title":"J Neuropathol Exp Neurol"},{"issue":"1","key":"339_CR124","doi-asserted-by":"crossref","first-page":"9403","DOI":"10.1038\/s41467-024-53658-8","volume":"15","author":"C Maguire","year":"2024","unstructured":"Maguire C, Wang C, Ramasamy A, Fonken C, Morse B, Lopez N, Wylie D, Melamed E (2024) Molecular mimicry as a mechanism of viral immune evasion and autoimmunity. Nat Commun 15(1):9403","journal-title":"Nat Commun"},{"issue":"3","key":"339_CR125","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s00281-006-0025-4","volume":"28","author":"G Makedonas","year":"2006","unstructured":"Makedonas G, Betts MR (2006) Polyfunctional analysis of human t cell responses: importance in vaccine immunogenicity and natural infection. Springer Semin Immunopathol 28(3):209\u2013219","journal-title":"Springer Semin Immunopathol"},{"issue":"6972","key":"339_CR126","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/nature02284","volume":"427","author":"M Matloubian","year":"2004","unstructured":"Matloubian M, Lo CG, Cinamon G, Lesneski MJ, Xu Y, Brinkmann V, Allende ML, Proia RL, Cyster JG (2004) Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1. Nature 427(6972):355\u2013360","journal-title":"Nature"},{"issue":"1","key":"339_CR127","doi-asserted-by":"crossref","first-page":"19973","DOI":"10.1038\/s41598-020-76344-3","volume":"10","author":"B Mbiribindi","year":"2020","unstructured":"Mbiribindi B, Pena JK, Arvedson MP, Moreno Romero C, McCarthy SR, Hatton OL, Esquivel CO, Martinez OM, Krams SM (2020) Epstein-Barr virus peptides derived from latent cycle proteins alter NKG2A + NK cell effector function. Sci Rep 10(1):19973","journal-title":"Sci Rep"},{"issue":"5","key":"339_CR128","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.4049\/jimmunol.1900377","volume":"203","author":"BJ Meckiff","year":"2019","unstructured":"Meckiff BJ, Ladell K, McLaren JE, Ryan GB, Leese AM, James EA, Price DA, Long HM (2019) Primary EBV infection induces an acute wave of activated antigen-specific cytotoxic CD4(+) T cells. J Immunol 203(5):1276\u20131287","journal-title":"J Immunol"},{"issue":"6","key":"339_CR129","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.mucimm.2023.08.001","volume":"16","author":"S Mehandru","year":"2023","unstructured":"Mehandru S, Colombel JF, Juarez J, Bugni J, Lindsay JO (2023) Understanding the molecular mechanisms of anti-trafficking therapies and their clinical relevance in inflammatory bowel disease. Mucosal Immunol 16(6):859\u2013870","journal-title":"Mucosal Immunol"},{"key":"339_CR130","doi-asserted-by":"crossref","DOI":"10.1016\/j.coi.2022.102211","volume":"77","author":"D Merkler","year":"2022","unstructured":"Merkler D, Vincenti I, Masson F, Liblau RS (2022) Tissue-resident CD8 T cells in central nervous system inflammatory diseases: present at the crime scene and \u2026guilty. Curr Opin Immunol 77:102211","journal-title":"Curr Opin Immunol"},{"issue":"Pt 6","key":"339_CR131","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1093\/brain\/awt108","volume":"136","author":"M Mohme","year":"2013","unstructured":"Mohme M, Hotz C, Stevanovic S, Binder T, Lee JH, Okoniewski M, Eiermann T, Sospedra M, Rammensee HG, Martin R (2013) HLA-DR15-derived self-peptides are involved in increased autologous T cell proliferation in multiple sclerosis. Brain 136(Pt 6):1783\u20131798","journal-title":"Brain"},{"issue":"10","key":"339_CR132","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1177\/1352458511408991","volume":"17","author":"KL Munger","year":"2011","unstructured":"Munger KL, Levin LI, O'Reilly EJ, Falk KI, Ascherio A (2011) Anti-Epstein-Barr virus antibodies as serological markers of multiple sclerosis: a prospective study among United States military personnel. Mult Scler 17(10):1185\u20131193","journal-title":"Mult Scler"},{"issue":"1","key":"339_CR133","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/icb.2016.71","volume":"95","author":"TH Nguyen","year":"2017","unstructured":"Nguyen TH, Bird NL, Grant EJ, Miles JJ, Thomas PG, Kotsimbos TC, Mifsud NA, Kedzierska K (2017) Maintenance of the EBV-specific CD8(+) TCRalphabeta repertoire in immunosuppressed lung transplant recipients. Immunol Cell Biol 95(1):77\u201386","journal-title":"Immunol Cell Biol"},{"issue":"9","key":"339_CR134","doi-asserted-by":"crossref","first-page":"3310","DOI":"10.1182\/blood-2007-05-086934","volume":"110","author":"M Niens","year":"2007","unstructured":"Niens M, Jarrett RF, Hepkema B, Nolte IM, Diepstra A, Platteel M, Kouprie N, Delury CP, Gallagher A, Visser L, Poppema S, te Meerman GJ, van den Berg A (2007) HLA-A*02 is associated with a reduced risk and HLA-A*01 with an increased risk of developing EBV+ Hodgkin lymphoma. Blood 110(9):3310\u20133315","journal-title":"Blood"},{"issue":"2","key":"339_CR135","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1365-2567.2011.03476.x","volume":"134","author":"RJ Ning","year":"2011","unstructured":"Ning RJ, Xu XQ, Chan KH, Chiang AK (2011) Long-term carriers generate Epstein-Barr virus (EBV)-specific CD4(+) and CD8(+) polyfunctional T-cell responses which show immunodominance hierarchies of EBV proteins. Immunology 134(2):161\u2013171","journal-title":"Immunology"},{"key":"339_CR136","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1177\/13524585221099844","volume":"28","author":"S Noteboom","year":"2022","unstructured":"Noteboom S, Arnold D, Bar-Or A, Pender M, Hodgkinson S, Broadley S, Lindsey JW, Ioannides ZA, Bagert B, Willmer J, Gamelin L, Ye W, Liu E, Schoonheim MM (2022) Long-term disability improvement during EBV-targeted T-cell immunotherapy ATA188 is related to brain volume change and normalised magnetisation transfer ratio in T2 lesions. Mult Scler J 28:1005\u20131006","journal-title":"Mult Scler J"},{"issue":"4","key":"339_CR137","doi-asserted-by":"crossref","DOI":"10.1111\/ene.70131","volume":"32","author":"A Nova","year":"2025","unstructured":"Nova A, Gentilini D, Di Caprio G, Bourguiba-Hachemi S, Vince N, Gourraud PA, Bernardinelli L, Fazia T (2025) Stratifying multiple sclerosis susceptibility risk: the role of HLA-E*01 and infectious mononucleosis in a population cohort. Eur J Neurol 32(4):e70131","journal-title":"Eur J Neurol"},{"issue":"12","key":"339_CR138","doi-asserted-by":"crossref","first-page":"3199","DOI":"10.1002\/eji.1830241243","volume":"24","author":"DL Orsini","year":"1994","unstructured":"Orsini DL, van Gils M, Kooy YM, Struyk L, Klein G, van den Elsen P, Koning F (1994) Functional and molecular characterization of B cell-responsive V delta 1+ gamma delta T cells. Eur J Immunol 24(12):3199\u20133204","journal-title":"Eur J Immunol"},{"issue":"4","key":"339_CR139","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0047-6374(03)00026-5","volume":"124","author":"Q Ouyang","year":"2003","unstructured":"Ouyang Q, Wagner WM, Walter S, Muller CA, Wikby A, Aubert G, Klatt T, Stevanovic S, Dodi T, Pawelec G (2003) An age-related increase in the number of CD8+ T cells carrying receptors for an immunodominant Epstein-Barr virus (EBV) epitope is counteracted by a decreased frequency of their antigen-specific responsiveness. Mech Ageing Dev 124(4):477\u2013485","journal-title":"Mech Ageing Dev"},{"issue":"8","key":"339_CR140","doi-asserted-by":"crossref","first-page":"3293","DOI":"10.1182\/blood-2008-02-138040","volume":"112","author":"U Palendira","year":"2008","unstructured":"Palendira U, Chinn R, Raza W, Piper K, Pratt G, Machado L, Bell A, Khan N, Hislop AD, Steyn R, Rickinson AB, Buckley CD, Moss P (2008) Selective accumulation of virus-specific CD8+ T cells with unique homing phenotype within the human bone marrow. Blood 112(8):3293\u20133302","journal-title":"Blood"},{"issue":"11","key":"339_CR141","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.it.2003.09.005","volume":"24","author":"MP Pender","year":"2003","unstructured":"Pender MP (2003) Infection of autoreactive B lymphocytes with EBV, causing chronic autoimmune diseases. Trends Immunol 24(11):584\u2013588","journal-title":"Trends Immunol"},{"issue":"4","key":"339_CR142","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1177\/1073858410381531","volume":"17","author":"MP Pender","year":"2011","unstructured":"Pender MP (2011) The essential role of Epstein-Barr virus in the pathogenesis of multiple sclerosis. Neuroscientist 17(4):351\u2013367","journal-title":"Neuroscientist"},{"issue":"1","key":"339_CR143","doi-asserted-by":"crossref","DOI":"10.1038\/cti.2016.87","volume":"6","author":"MP Pender","year":"2017","unstructured":"Pender MP, Csurhes PA, Burrows JM, Burrows SR (2017) Defective T-cell control of Epstein-Barr virus infection in multiple sclerosis. Clin Transl Immunol 6(1):e126","journal-title":"Clin Transl Immunol"},{"key":"339_CR144","doi-asserted-by":"crossref","unstructured":"Pender MP, Csurhes PA, Smith C, Douglas NL, Neller MA, Matthews KK, Beagley L, Rehan S, Crooks P, Hopkins TJ, Blum S, Green KA, Ioannides ZA, Swayne A, Aftab BT, Hooper KD, Burrows SR, Thompson KM, Coulthard A, Khanna R (2018) Epstein-Barr virus-specific T cell therapy for progressive multiple sclerosis. JCI Insight 3(22):e124714.","DOI":"10.1172\/jci.insight.124714"},{"issue":"3","key":"339_CR145","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1084\/jem.20072525","volume":"205","author":"EJ Petrie","year":"2008","unstructured":"Petrie EJ, Clements CS, Lin J, Sullivan LC, Johnson D, Huyton T, Heroux A, Hoare HL, Beddoe T, Reid HH, Wilce MC, Brooks AG, Rossjohn J (2008) CD94-NKG2A recognition of human leukocyte antigen (HLA)-E bound to an HLA class I leader sequence. J Exp Med 205(3):725\u2013735","journal-title":"J Exp Med"},{"issue":"5","key":"339_CR146","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.4049\/jimmunol.170.5.2590","volume":"170","author":"ML Precopio","year":"2003","unstructured":"Precopio ML, Sullivan JL, Willard C, Somasundaran M, Luzuriaga K (2003) Differential kinetics and specificity of EBV-specific CD4+ and CD8+ T cells during primary infection. J Immunol 170(5):2590\u20132598","journal-title":"J Immunol"},{"issue":"10","key":"339_CR147","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1084\/jem.20051357","volume":"202","author":"DA Price","year":"2005","unstructured":"Price DA, Brenchley JM, Ruff LE, Betts MR, Hill BJ, Roederer M, Koup RA, Migueles SA, Gostick E, Wooldridge L, Sewell AK, Connors M, Douek DC (2005) Avidity for antigen shapes clonal dominance in CD8+ T cell populations specific for persistent DNA viruses. J Exp Med 202(10):1349\u20131361","journal-title":"J Exp Med"},{"issue":"3","key":"339_CR148","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1084\/jem.20041542","volume":"201","author":"VA Pudney","year":"2005","unstructured":"Pudney VA, Leese AM, Rickinson AB, Hislop AD (2005) CD8+ immunodominance among Epstein-Barr virus lytic cycle antigens directly reflects the efficiency of antigen presentation in lytically infected cells. J Exp Med 201(3):349\u2013360","journal-title":"J Exp Med"},{"issue":"3","key":"339_CR149","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s10238-020-00621-8","volume":"20","author":"J Qian","year":"2020","unstructured":"Qian J, Yu Q, Chen G, Wang M, Zhao Z, Zhang Y, Qiu L (2020) Altered ratio of circulating follicular regulatory T cells and follicular helper T cells during primary EBV infection. Clin Exp Med 20(3):373\u2013380","journal-title":"Clin Exp Med"},{"issue":"2","key":"339_CR150","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.bjid.2012.09.008","volume":"17","author":"N Ramroodi","year":"2013","unstructured":"Ramroodi N, Niazi AA, Sanadgol N, Ganjali Z, Sarabandi V (2013) Evaluation of reactive Epstein-Barr virus (EBV) in Iranian patient with different subtypes of multiple sclerosis (MS). Braz J Infect Dis 17(2):156\u2013163","journal-title":"Braz J Infect Dis"},{"issue":"1","key":"339_CR151","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1128\/JVI.02003-14","volume":"89","author":"EB Remmerswaal","year":"2015","unstructured":"Remmerswaal EB, Klarenbeek PL, Alves NL, Doorenspleet ME, van Schaik BD, Esveldt RE, Idu MM, van Leeuwen EM, van der Bom-Baylon N, van Kampen AH, Koch SD, Pircher H, Bemelman FJ, Ten Brinke A, Baas F, Ten Berge IJ, van Lier RA, de Vries N (2015) Clonal evolution of CD8+ T cell responses against latent viruses: relationship among phenotype, localization, and function. J Virol 89(1):568\u2013580","journal-title":"J Virol"},{"issue":"2","key":"339_CR152","volume":"16","author":"JC Romero-Masters","year":"2020","unstructured":"Romero-Masters JC, Huebner SM, Ohashi M, Bristol JA, Benner BE, Barlow EA, Turk GL, Nelson SE, Baiu DC, Van Sciver N, Ranheim EA, Gumperz J, Sherer NM, Farrell PJ, Johannsen EC, Kenney SC (2020) B cells infected with type 2 Epstein-Barr virus (EBV) have increased NFATc1\/NFATc2 activity and enhanced lytic gene expression in comparison to type 1 EBV infection. PLoS Pathog 16(2):e1008365","journal-title":"PLoS Pathog"},{"issue":"6754","key":"339_CR153","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/44385","volume":"401","author":"F Sallusto","year":"1999","unstructured":"Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A (1999) Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401(6754):708\u2013712","journal-title":"Nature"},{"issue":"14","key":"339_CR154","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1212\/WNL.0b013e3181d865a1","volume":"74","author":"SA Sargsyan","year":"2010","unstructured":"Sargsyan SA, Shearer AJ, Ritchie AM, Burgoon MP, Anderson S, Hemmer B, Stadelmann C, Gattenlohner S, Owens GP, Gilden D, Bennett JL (2010) Absence of Epstein-Barr virus in the brain and CSF of patients with multiple sclerosis. Neurology 74(14):1127\u20131135","journal-title":"Neurology"},{"issue":"2","key":"339_CR155","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1365-2249.2008.03699.x","volume":"153","author":"J Scherrenburg","year":"2008","unstructured":"Scherrenburg J, Piriou ER, Nanlohy NM, van Baarle D (2008) Detailed analysis of Epstein-Barr virus-specific CD4+ and CD8+ T cell responses during infectious mononucleosis. Clin Exp Immunol 153(2):231\u2013239","journal-title":"Clin Exp Immunol"},{"key":"339_CR156","doi-asserted-by":"crossref","unstructured":"Schneider-Hohendorf T, Gerdes LA, Pignolet B, Gittelman R, Ostkamp P, Rubelt F, Raposo C, Tackenberg B, Riepenhausen M, Janoschka C, Wunsch C, Bucciarelli F, Flierl-Hecht A, Beltran E, Kumpfel T, Anslinger K, Gross CC, Chapman H, Kaplan I, Brassat D, Wekerle H, Kerschensteiner M, Klotz L, Lunemann JD, Hohlfeld R, Liblau R, Wiendl H, Schwab N (2022) Broader Epstein-Barr virus-specific T cell receptor repertoire in patients with multiple sclerosis. J Exp Med 219(11):e20220650.","DOI":"10.1084\/jem.20220650"},{"issue":"3","key":"339_CR157","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1093\/brain\/awae244","volume":"148","author":"T Schneider-Hohendorf","year":"2025","unstructured":"Schneider-Hohendorf T, Wunsch C, Falk S, Raposo C, Rubelt F, Mirebrahim H, Asgharian H, Schlecht U, Mattox D, Zhou W, Dawin E, Pawlitzki M, Lauks S, Jarius S, Wildemann B, Havla J, Kumpfel T, Schrot MC, Ringelstein M, Kraemer M, Schwake C, Schmitter T, Ayzenberg I, Fischer K, Meuth SG, Aktas O, Hummert MW, Kretschmer JR, Trebst C, Kleffner I, Massey J, Muraro PA, Chen-Harris H, Gross CC, Klotz L, Wiendl H, Schwab N (2025) Broader anti-EBV TCR repertoire in multiple sclerosis: disease specificity and treatment modulation. Brain 148(3):933\u2013940","journal-title":"Brain"},{"issue":"9","key":"339_CR158","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1016\/j.celrep.2016.04.081","volume":"15","author":"Z Sebestyen","year":"2016","unstructured":"Sebestyen Z, Scheper W, Vyborova A, Gu S, Rychnavska Z, Schiffler M, Cleven A, Cheneau C, van Noorden M, Peigne CM, Olive D, Lebbink RJ, Oostvogels R, Mutis T, Schuurhuis GJ, Adams EJ, Scotet E, Kuball J (2016) RhoB mediates Phosphoantigen recognition by Vgamma9Vdelta2 T cell receptor. Cell Rep 15(9):1973\u20131985","journal-title":"Cell Rep"},{"issue":"12","key":"339_CR159","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1084\/jem.20071030","volume":"204","author":"B Serafini","year":"2007","unstructured":"Serafini B, Rosicarelli B, Franciotta D, Magliozzi R, Reynolds R, Cinque P, Andreoni L, Trivedi P, Salvetti M, Faggioni A, Aloisi F (2007) Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain. J Exp Med 204(12):2899\u20132912","journal-title":"J Exp Med"},{"issue":"7","key":"339_CR160","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1097\/NEN.0b013e3181e332ec","volume":"69","author":"B Serafini","year":"2010","unstructured":"Serafini B, Severa M, Columba-Cabezas S, Rosicarelli B, Veroni C, Chiappetta G, Magliozzi R, Reynolds R, Coccia EM, Aloisi F (2010) Epstein-Barr virus latent infection and BAFF expression in B cells in the multiple sclerosis brain: implications for viral persistence and intrathecal B-cell activation. J Neuropathol Exp Neurol 69(7):677\u2013693","journal-title":"J Neuropathol Exp Neurol"},{"key":"339_CR161","doi-asserted-by":"crossref","unstructured":"Serafini B, Rosicarelli B, Veroni C, Mazzola GA, Aloisi F (2019) Epstein-Barr virus-specific CD8 T cells selectively infiltrate the brain in multiple sclerosis and interact locally with virus-infected cells: clue for a virus-driven Immunopathological mechanism. J Virol 93(24):e00980-19.","DOI":"10.1128\/JVI.00980-19"},{"issue":"9","key":"339_CR162","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/nri3279","volume":"12","author":"AK Sewell","year":"2012","unstructured":"Sewell AK (2012) Why must T cells be cross-reactive? Nat Rev Immunol 12(9):669\u2013677","journal-title":"Nat Rev Immunol"},{"issue":"7083","key":"339_CR163","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/nature04606","volume":"440","author":"LR Shiow","year":"2006","unstructured":"Shiow LR, Rosen DB, Brdickova N, Xu Y, An J, Lanier LL, Cyster JG, Matloubian M (2006) CD69 acts downstream of interferon-alpha\/beta to inhibit S1P1 and lymphocyte egress from lymphoid organs. Nature 440(7083):540\u2013544","journal-title":"Nature"},{"issue":"13","key":"339_CR164","doi-asserted-by":"crossref","first-page":"3739","DOI":"10.1182\/blood.V98.13.3739","volume":"98","author":"SL Silins","year":"2001","unstructured":"Silins SL, Sherritt MA, Silleri JM, Cross SM, Elliott SL, Bharadwaj M, Le TT, Morrison LE, Khanna R, Moss DJ, Suhrbier A, Misko IS (2001) Asymptomatic primary Epstein-Barr virus infection occurs in the absence of blood T-cell repertoire perturbations despite high levels of systemic viral load. Blood 98(13):3739\u20133744","journal-title":"Blood"},{"issue":"1","key":"339_CR165","doi-asserted-by":"crossref","first-page":"112","DOI":"10.4049\/jimmunol.1900455","volume":"204","author":"CJ Smith","year":"2020","unstructured":"Smith CJ, Venturi V, Quigley MF, Turula H, Gostick E, Ladell K, Hill BJ, Himelfarb D, Quinn KM, Greenaway HY, Dang THY, Seder RA, Douek DC, Hill AB, Davenport MP, Price DA, Snyder CM (2020) Stochastic expansions maintain the clonal stability of CD8(+) T cell populations undergoing memory inflation driven by murine cytomegalovirus. J Immunol 204(1):112\u2013121","journal-title":"J Immunol"},{"issue":"1","key":"339_CR166","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1182\/blood-2003-06-1791","volume":"103","author":"MV Soares","year":"2004","unstructured":"Soares MV, Plunkett FJ, Verbeke CS, Cook JE, Faint JM, Belaramani LL, Fletcher JM, Hammerschmitt N, Rustin M, Bergler W, Beverley PC, Salmon M, Akbar AN (2004) Integration of apoptosis and telomere erosion in virus-specific CD8+ T cells from blood and tonsils during primary infection. Blood 103(1):162\u2013167","journal-title":"Blood"},{"issue":"1","key":"339_CR167","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s41579-022-00770-5","volume":"21","author":"SS Soldan","year":"2023","unstructured":"Soldan SS, Lieberman PM (2023) Epstein-Barr virus and multiple sclerosis. Nat Rev Microbiol 21(1):51\u201364","journal-title":"Nat Rev Microbiol"},{"issue":"1","key":"339_CR168","doi-asserted-by":"crossref","first-page":"6394","DOI":"10.1038\/s41467-025-61627-y","volume":"16","author":"I Sturmlechner","year":"2025","unstructured":"Sturmlechner I, Jain A, Hu B, Jadhav RR, Cao W, Okuyama H, Tian L, Weyand CM, Goronzy JJ (2025) Antigen specificity shapes distinct aging trajectories of memory CD8(+) T cells. Nat Commun 16(1):6394","journal-title":"Nat Commun"},{"issue":"2","key":"339_CR169","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.advms.2014.04.003","volume":"59","author":"A Sulik","year":"2014","unstructured":"Sulik A, Oldak E, Kroten A, Lipska A, Radziwon P (2014) Epstein-Barr virus effect on frequency of functionally distinct T cell subsets in children with infectious mononucleosis. Adv Med Sci 59(2):227\u2013231","journal-title":"Adv Med Sci"},{"issue":"1","key":"339_CR170","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/gene.2011.42","volume":"13","author":"E Sundqvist","year":"2012","unstructured":"Sundqvist E, Sundstrom P, Linden M, Hedstrom AK, Aloisi F, Hillert J, Kockum I, Alfredsson L, Olsson T (2012) Epstein-Barr virus and multiple sclerosis: interaction with HLA. Genes Immun 13(1):14\u201320","journal-title":"Genes Immun"},{"key":"339_CR171","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1146\/annurev-immunol-032414-112326","volume":"33","author":"GS Taylor","year":"2015","unstructured":"Taylor GS, Long HM, Brooks JM, Rickinson AB, Hislop AD (2015) The immunology of Epstein-Barr virus-induced disease. Annu Rev Immunol 33:787\u2013821","journal-title":"Annu Rev Immunol"},{"key":"339_CR172","doi-asserted-by":"crossref","first-page":"1304281","DOI":"10.3389\/fimmu.2023.1304281","volume":"14","author":"OG Thomas","year":"2023","unstructured":"Thomas OG, Olsson T (2023) Mimicking the brain: Epstein-Barr virus and foreign agents as drivers of neuroimmune attack in multiple sclerosis. Front Immunol 14:1304281","journal-title":"Front Immunol"},{"issue":"5","key":"339_CR173","doi-asserted-by":"crossref","DOI":"10.1002\/cti2.1451","volume":"12","author":"OG Thomas","year":"2023","unstructured":"Thomas OG, Rickinson A, Palendira U (2023a) Epstein-Barr virus and multiple sclerosis: moving from questions of association to questions of mechanism. Clin Transl Immunol 12(5):e1451","journal-title":"Clin Transl Immunol"},{"issue":"20","key":"339_CR174","doi-asserted-by":"crossref","first-page":"eadg3032","DOI":"10.1126\/sciadv.adg3032","volume":"9","author":"OG Thomas","year":"2023","unstructured":"Thomas OG, Bronge M, Tengvall K, Akpinar B, Nilsson OB, Holmgren E, Hessa T, Gafvelin G, Khademi M, Alfredsson L, Martin R, Guerreiro-Cacais AO, Gronlund H, Olsson T, Kockum I (2023b) Cross-reactive EBNA1 immunity targets alpha-crystallin B and is associated with multiple sclerosis. Sci Adv 9(20):eadg3032","journal-title":"Sci Adv"},{"issue":"6","key":"339_CR175","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1012177","volume":"20","author":"OG Thomas","year":"2024","unstructured":"Thomas OG, Haigh TA, Croom-Carter D, Leese A, Van Wijck Y, Douglas MR, Rickinson A, Brooks JM, Taylor GS (2024) Heightened Epstein-Barr virus immunity and potential cross-reactivities in multiple sclerosis. PLoS Pathog 20(6):e1012177","journal-title":"PLoS Pathog"},{"issue":"11","key":"339_CR176","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.1002\/1521-4141(200211)32:11<3181::AID-IMMU3181>3.0.CO;2-2","volume":"32","author":"L Trautmann","year":"2002","unstructured":"Trautmann L, Labarriere N, Jotereau F, Karanikas V, Gervois N, Connerotte T, Coulie P, Bonneville M (2002) Dominant TCR V alpha usage by virus and tumor-reactive T cells with wide affinity ranges for their specific antigens. Eur J Immunol 32(11):3181\u20133190","journal-title":"Eur J Immunol"},{"issue":"9","key":"339_CR177","doi-asserted-by":"crossref","first-page":"4375","DOI":"10.4049\/jimmunol.160.9.4375","volume":"160","author":"M Ulbrecht","year":"1998","unstructured":"Ulbrecht M, Modrow S, Srivastava R, Peterson PA, Weiss EH (1998) Interaction of HLA-E with peptides and the peptide transporter in vitro: implications for its function in antigen presentation. J Immunol 160(9):4375\u20134385","journal-title":"J Immunol"},{"issue":"3","key":"339_CR178","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1177\/1352458515588581","volume":"22","author":"GP van Nierop","year":"2016","unstructured":"van Nierop GP, Mautner J, Mitterreiter JG, Hintzen RQ, Verjans GM (2016) Intrathecal CD8 T-cells of multiple sclerosis patients recognize lytic Epstein-Barr virus proteins. Mult Scler 22(3):279\u2013291","journal-title":"Mult Scler"},{"issue":"3","key":"339_CR179","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s00401-017-1744-4","volume":"134","author":"GP van Nierop","year":"2017","unstructured":"van Nierop GP, van Luijn MM, Michels SS, Melief MJ, Janssen M, Langerak AW, Ouwendijk WJD, Hintzen RQ, Verjans G (2017) Phenotypic and functional characterization of T cells in white matter lesions of multiple sclerosis patients. Acta Neuropathol 134(3):383\u2013401","journal-title":"Acta Neuropathol"},{"key":"339_CR180","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.665718","volume":"12","author":"C Veroni","year":"2021","unstructured":"Veroni C, Aloisi F (2021) The CD8 T cell-Epstein-Barr virus-B cell Trialogue: a central issue in multiple sclerosis pathogenesis. Front Immunol 12:665718","journal-title":"Front Immunol"},{"issue":"13","key":"339_CR181","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1182\/blood.2022017650","volume":"141","author":"H Vietzen","year":"2023","unstructured":"Vietzen H, Furlano PL, Cornelissen JJ, Bohmig GA, Jaksch P, Puchhammer-Stockl E (2023a) HLA-E-restricted immune responses are crucial for the control of EBV infections and the prevention of PTLD. Blood 141(13):1560\u20131573","journal-title":"Blood"},{"issue":"26","key":"339_CR182","doi-asserted-by":"crossref","first-page":"5705","DOI":"10.1016\/j.cell.2023.11.015","volume":"186","author":"H Vietzen","year":"2023","unstructured":"Vietzen H, Berger SM, Kuhner LM, Furlano PL, Bsteh G, Berger T, Rommer P, Puchhammer-Stockl E (2023b) Ineffective control of Epstein-Barr-virus-induced autoimmunity increases the risk for multiple sclerosis. Cell 186(26):5705\u20135718 e13","journal-title":"Cell"},{"issue":"5\u20136","key":"339_CR183","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s00430-018-0553-2","volume":"207","author":"AG Vistarop","year":"2018","unstructured":"Vistarop AG, Cohen M, Huaman F, Irazu L, Rodriguez M, De Matteo E, Preciado MV, Chabay PA (2018) The interplay between local immune response and Epstein-Barr virus-infected tonsillar cells could lead to viral infection control. Med Microbiol Immunol 207(5\u20136):319\u2013327","journal-title":"Med Microbiol Immunol"},{"issue":"8","key":"339_CR184","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s00415-025-13248-0","volume":"272","author":"BK Vitturi","year":"2025","unstructured":"Vitturi BK, Cellerino M, Boccia D, Leray E, Correale J, Dobson R, van der Mei I, Fujihara K, Inglese M (2025) Environmental risk factors for multiple sclerosis: a comprehensive systematic review and meta-analysis. J Neurol 272(8):513","journal-title":"J Neurol"},{"issue":"5","key":"339_CR185","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/j.cell.2020.09.054","volume":"183","author":"J Wang","year":"2020","unstructured":"Wang J, Jelcic I, Muhlenbruch L, Haunerdinger V, Toussaint NC, Zhao Y, Cruciani C, Faigle W, Naghavian R, Foege M, Binder TMC, Eiermann T, Opitz L, Fuentes-Font L, Reynolds R, Kwok WW, Nguyen JT, Lee JH, Lutterotti A, Munz C, Rammensee HG, Hauri-Hohl M, Sospedra M, Stevanovic S, Martin R (2020) HLA-DR15 molecules jointly shape an autoreactive T cell repertoire in multiple sclerosis. Cell 183(5):1264\u20131281 e20","journal-title":"Cell"},{"key":"339_CR186","volume":"12","author":"Y Wang","year":"2021","unstructured":"Wang Y, Luo Y, Tang G, Ouyang R, Zhang M, Jiang Y, Wang T, Zhang X, Yin B, Huang J, Wei W, Huang M, Wang F, Wu S, Hou H (2021) HLA-DR expression level in CD8(+) T cells correlates with the severity of children with acute infectious mononucleosis. Front Immunol 12:753290","journal-title":"Front Immunol"},{"issue":"1","key":"339_CR187","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/imr.12928","volume":"298","author":"CR Willcox","year":"2020","unstructured":"Willcox CR, Mohammed F, Willcox BE (2020) The distinct MHC-unrestricted immunobiology of innate-like and adaptive-like human gammadelta T cell subsets-nature's CAR-T cells. Immunol Rev 298(1):25\u201346","journal-title":"Immunol Rev"},{"issue":"2","key":"339_CR188","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1365-2141.2005.05452.x","volume":"129","author":"H Williams","year":"2005","unstructured":"Williams H, McAulay K, Macsween KF, Gallacher NJ, Higgins CD, Harrison N, Swerdlow AJ, Crawford DH (2005) The immune response to primary EBV infection: a role for natural killer cells. Br J Haematol 129(2):266\u2013274","journal-title":"Br J Haematol"},{"issue":"Pt 12","key":"339_CR189","doi-asserted-by":"crossref","first-page":"3318","DOI":"10.1093\/brain\/awp200","volume":"132","author":"SN Willis","year":"2009","unstructured":"Willis SN, Stadelmann C, Rodig SJ, Caron T, Gattenloehner S, Mallozzi SS, Roughan JE, Almendinger SE, Blewett MM, Bruck W, Hafler DA, O'Connor KC (2009) Epstein-Barr virus infection is not a characteristic feature of multiple sclerosis brain. Brain 132(Pt 12):3318\u20133328","journal-title":"Brain"},{"key":"339_CR190","doi-asserted-by":"crossref","first-page":"6","DOI":"10.7554\/eLife.27364","volume":"6","author":"MB Winter","year":"2017","unstructured":"Winter MB, La Greca F, Arastu-Kapur S, Caiazza F, Cimermancic P, Buchholz TJ, Anderl JL, Ravalin M, Bohn MF, Sali A, O'Donoghue AJ, Craik CS (2017) Immunoproteasome functions explained by divergence in cleavage specificity and regulation. elife 6:6","journal-title":"elife"},{"issue":"9","key":"339_CR191","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1086\/491741","volume":"192","author":"T Woodberry","year":"2005","unstructured":"Woodberry T, Suscovich TJ, Henry LM, Davis JK, Frahm N, Walker BD, Scadden DT, Wang F, Brander C (2005) Differential targeting and shifts in the immunodominance of Epstein-Barr virus\u2013specific CD8 and CD4 T cell responses during acute and persistent infection. J Infect Dis 192(9):1513\u20131524","journal-title":"J Infect Dis"},{"issue":"8","key":"339_CR192","volume":"12","author":"HG Woon","year":"2016","unstructured":"Woon HG, Braun A, Li J, Smith C, Edwards J, Sierro F, Feng CG, Khanna R, Elliot M, Bell A, Hislop AD, Tangye SG, Rickinson AB, Gebhardt T, Britton WJ, Palendira U (2016) Compartmentalization of Total and virus-specific tissue-resident memory CD8+ T cells in human lymphoid organs. PLoS Pathog 12(8):e1005799","journal-title":"PLoS Pathog"},{"issue":"5","key":"339_CR193","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/0092-8674(95)90348-8","volume":"80","author":"KW Wucherpfennig","year":"1995","unstructured":"Wucherpfennig KW, Strominger JL (1995) Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell 80(5):695\u2013705","journal-title":"Cell"},{"issue":"8","key":"339_CR194","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0105434","volume":"9","author":"SC Wuest","year":"2014","unstructured":"Wuest SC, Mexhitaj I, Chai NR, Romm E, Scheffel J, Xu B, Lane K, Wu T, Bielekova B (2014) A complex role of herpes viruses in the disease process of multiple sclerosis. PLoS One 9(8):e105434","journal-title":"PLoS One"},{"issue":"4","key":"339_CR195","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.ccr.2014.07.026","volume":"26","author":"Z Xiang","year":"2014","unstructured":"Xiang Z, Liu Y, Zheng J, Liu M, Lv A, Gao Y, Hu H, Lam KT, Chan GC, Yang Y, Chen H, Tsao GS, Bonneville M, Lau YL, Tu W (2014) Targeted activation of human Vgamma9Vdelta2-T cells controls epstein-barr virus-induced B cell lymphoproliferative disease. Cancer Cell 26(4):565\u2013576","journal-title":"Cancer Cell"},{"issue":"1","key":"339_CR196","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/eji.202048655","volume":"51","author":"H Zdimerova","year":"2021","unstructured":"Zdimerova H, Murer A, Engelmann C, Raykova A, Deng Y, Gujer C, Ruhl J, McHugh D, Caduff N, Naghavian R, Pezzino G, Capaul R, Zbinden A, Ferlazzo G, Lunemann JD, Martin R, Chatterjee B, Munz C (2021) Attenuated immune control of Epstein-Barr virus in humanized mice is associated with the multiple sclerosis risk factor HLA-DR15. Eur J Immunol 51(1):64\u201375","journal-title":"Eur J Immunol"},{"key":"339_CR197","doi-asserted-by":"crossref","first-page":"1060053","DOI":"10.3389\/fped.2023.1060053","volume":"11","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Huang C, Zhang H, Duan Z, Liu Q, Li J, Zong Q, Wei Y, Liu F, Duan W, Chen L, Zhou Q, Wang Q (2023) Characteristics of immunological events in Epstein-Barr virus infection in children with infectious mononucleosis. Front Pediatr 11:1060053","journal-title":"Front Pediatr"},{"issue":"1","key":"339_CR198","doi-asserted-by":"crossref","first-page":"17775","DOI":"10.1038\/s41598-017-18195-z","volume":"7","author":"H Zhong","year":"2017","unstructured":"Zhong H, Hu X, Janowski AB, Storch GA, Su L, Cao L, Yu J, Xu J (2017) Whole transcriptome profiling reveals major cell types in the cellular immune response against acute and chronic active Epstein-Barr virus infection. Sci Rep 7(1):17775","journal-title":"Sci Rep"},{"key":"339_CR199","doi-asserted-by":"publisher","unstructured":"Zuo J, Jin DY (2025) Immune evasion by Epstein-Barr virus. Curr Top Microbiol Immunol. https:\/\/doi.org\/10.1007\/82_2025_311","DOI":"10.1007\/82_2025_311"}],"container-title":["Current Topics in Microbiology and Immunology"],"original-title":[],"link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/82_2025_339","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T14:06:23Z","timestamp":1770386783000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/82_2025_339"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":199,"URL":"https:\/\/doi.org\/10.1007\/82_2025_339","relation":{},"ISSN":["0070-217X","2196-9965"],"issn-type":[{"value":"0070-217X","type":"print"},{"value":"2196-9965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"7 February 2026","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}